Shanghai Changzheng Hospital

This early-phase study tests a new drug called LC-K76 combined with standard hormone therapy in 40 men with metastatic hormone-sensitive prostate cancer. The main goal is to check safety and see if the drug helps lower PSA levels. Participants will take the drug for 24 weeks and …

This early-stage study tests a new drug (LC-K76) combined with an immunotherapy (Tislelizumab) in 10 men with metastatic castration-resistant prostate cancer that has worsened after standard treatments. The goal is to see if the combination is safe and shows signs of controlling …

This study looks at whether giving radiotherapy after surgery for cancer that has spread to the spine helps patients live longer or have better quality of life. About 130 adults who had recent spinal surgery will be followed to compare those who get radiation and those who do not…

This study is testing a new blood test that uses advanced quantum sensors and artificial intelligence to find tiny bits of DNA from prostate cancer cells. The goal is to diagnose prostate cancer earlier and more accurately, potentially reducing the need for invasive biopsies. The…

This study follows 150 adults with paralysis from cancer that spread to the spine. All participants will have surgery to relieve pressure on the spinal cord. Researchers will track how well their movement, bladder, and bowel function recover over 12 months. The goal is to find wh…